4.7 Letter

IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK

Journal

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 72, Issue 7, Pages 2129-2131

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/jac/dkx103

Keywords

-

Funding

  1. Accelerate Diagnostics
  2. Achaogen Inc.
  3. Allecra Therapeutics
  4. Amplex
  5. AstraZeneca UK Ltd
  6. Basilea Pharmaceutica
  7. Becton Dickinson Diagnostics
  8. bioMerieux
  9. Bio-Rad Laboratories
  10. BSAC
  11. Cepheid
  12. Check-Points B.V.
  13. Cubist Pharmaceuticals
  14. Department of Health
  15. Enigma Diagnostics
  16. Food Standards Agency
  17. GlaxoSmithKline Services Ltd
  18. Henry Stewart Talks
  19. IHMA Ltd
  20. Kalidex Pharmaceuticals
  21. Melinta Therapeutics
  22. Merck Sharpe Dohme Corp.
  23. Meiji Seika Pharmo Co. Ltd
  24. Mobidiag
  25. Momentum Biosciences Ltd
  26. Nordic Pharma Ltd
  27. Norgine Pharmaceuticals
  28. Rempex Pharmaceuticals Ltd
  29. Roche
  30. Rokitan Ltd
  31. Smith Nephew UK Ltd
  32. Trius Therapeutics
  33. VenatoRx Pharmaceuticals
  34. Wockhardt Ltd.

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available